Home326030 • KRX
add
SK Biopharmaceuticals Co Ltd
Previous close
₩104,300.00
Day range
₩102,400.00 - ₩104,900.00
Year range
₩72,600.00 - ₩130,000.00
Market cap
8.08T KRW
Avg Volume
121.97K
P/E ratio
33.57
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 163.02B | 28.61% |
Operating expense | 116.49B | 18.87% |
Net income | 190.12B | 2,712.44% |
Net profit margin | 116.62 | 2,087.99% |
Earnings per share | — | — |
EBITDA | 45.12B | 134.07% |
Effective tax rate | -491.00% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 324.49B | 34.58% |
Total assets | 1.04T | 43.37% |
Total liabilities | 462.83B | 15.07% |
Total equity | 573.98B | — |
Shares outstanding | 78.31M | — |
Price to book | 14.95 | — |
Return on assets | 11.22% | — |
Return on capital | 15.62% | — |
Cash Flow
Net change in cash
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 190.12B | 2,712.44% |
Cash from operations | 56.85B | 410.51% |
Cash from investing | -2.38B | 1.60% |
Cash from financing | -1.12B | 88.64% |
Net change in cash | 56.78B | 279.15% |
Free cash flow | 36.61B | 264.93% |
About
Founded
1993
Website
